Proto Labs Inc: Form 10-Q for the period ended Mar 31, 2019
Filed with the SEC on Apr 30, 2019 and accepted by EDGAR at Apr 30, 2019, 11:59 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2019-01-01 to 2019-03-31 | $113.5m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 3 months2019-01-01 to 2019-03-31 | $54.6m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2019-01-01 to 2019-03-31 | $58.9m | us-gaap:GrossProfit |
| Research and development | 3 months2019-01-01 to 2019-03-31 | $8.0m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2019-01-01 to 2019-03-31 | $19.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2019-01-01 to 2019-03-31 | $4.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2019-01-01 to 2019-03-31 | $15.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2019-01-01 to 2019-03-31 | $0.57 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2019-01-01 to 2019-03-31 | $0.58 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2019-01-01 to 2019-03-31 | 27,177,039 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2019-01-01 to 2019-03-31 | $18.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2019-01-01 to 2019-03-31 | $12.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months2019-01-01 to 2019-03-31 | $17.3m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2019-03-31 | $85.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-03-31 | $202.8m | us-gaap:AssetsCurrent |
| Total assets | At period end2019-03-31 | $618.6m | us-gaap:Assets |
| Current liabilities | At period end2019-03-31 | $41.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2019-03-31 | $75.8m | us-gaap:Liabilities |
| Shareholders' equity | At period end2019-03-31 | $542.8m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-19-008260. Last ingested by Listed: Nov 4, 2026, 18:20 ET. Listed shows no prices and gives no investment advice.